(Q36986531)

17 August 2017

1 reference

title

Mass spectrometry and peptide-based vaccine development (English)

1 reference

17 August 2017

Ovsyannikova IG

1

1 reference

17 August 2017

Johnson KL

series ordinal

2

1 reference

17 August 2017

Bergen HR 3rd

series ordinal

3

1 reference

17 August 2017

Poland GA

series ordinal

4

1 reference

17 August 2017

language of work or name

English

0 references

publication date

31 October 2007

1 reference

Clinical Pharmacology & Therapeutics

17 August 2017

published in

1 reference

17 August 2017

volume

82

1 reference

17 August 2017

issue

6

1 reference

17 August 2017

page(s)

644-652

1 reference

HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

Mass tag-assisted identification of naturally processed HLA class II-presented meningococcal peptides recognized by CD4+ T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

Disruption of MHC class II-restricted antigen presentation by vaccinia virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

The role of mass spectrometry in vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Identification of protective and non-protective T cell epitopes in influenza

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Peptide-based therapeutic vaccines for allergic and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Lipopeptide vaccines--yesterday, today, and tomorrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Evaluation of T-cell responses to peptides and lipopeptides with MHC class I binding motifs derived from the amino acid sequence of the 19-kDa lipoprotein of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

New tools, new approaches and new ideas for vaccine development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Epitope-based vaccines: an update on epitope identification, vaccine design and delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Accurate mass precursor ion data and tandem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Immunodominance in TCD8+ responses to viruses: cell biology, cellular immunology, and mathematical models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Identification by mass spectrometry of CD8(+)-T-cell Mycobacterium tuberculosis epitopes within the Rv0341 gene product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Identical peptides recognized by MHC class I- and II-restricted T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Peptides recognized by class I restricted T cells also bind to MHC class II molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Identification of class II HLA-DRB1*03-bound measles virus peptides by 2D-liquid chromatography tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Automated protein identification by tandem mass spectrometry: issues and strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

The application of proteomics in defining the T cell antigens of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Stable isotope tagging of epitopes: a highly selective strategy for the identification of major histocompatibility complex class I-associated peptides induced upon viral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Electron capture dissociation for structural characterization of multiply charged protein cations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Counting individual sulfur atoms in a protein by ultrahigh-resolution Fourier transform ion cyclotron resonance mass spectrometry: experimental resolution of isotopic fine structure in proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Probing Proteomes Using Capillary Isoelectric Focusing-Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Use of double-depleted 13C and 15N culture media for analysis of whole cell bacteria by MALDI time-of-flight and Fourier transform mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Improved mass analysis of oligoribonucleotides by 13C, 15N double depletion and electrospray ionization FT-ICR mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

The minimal number of class II MHC-antigen complexes needed for T cell activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Optimized peptide separation and identification for mass spectrometry based proteomics via free-flow electrophoresis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

In-gel isoelectric focusing of peptides as a tool for improved protein identification.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

A comparison of immobilized pH gradient isoelectric focusing and strong-cation-exchange chromatography as a first dimension in shotgun proteomics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

A new liquid chromatography/tandem mass spectrometric approach for the identification of class I major histocompatibility complex associated peptides that eliminates the need for bioassays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

SYFPEITHI: database for MHC ligands and peptide motifs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Integrating epitope data into the emerging web of biomedical knowledge resources

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Demonstration of virus-specific CD8+ memory T cells in measles-seropositive individuals by in vitro peptide stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Dynamics of measles virus protein expression are reflected in the MHC class I epitope display

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Recognition of intracellular measles virus antigens by HLA class II restricted measles virus-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Efficient MHC class II-restricted presentation of measles virus to T cells relies on its targeting to its cellular receptor human CD46 and involves an endosomal pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Effect of measles virus infection on MHC class II expression and antigen presentation in human monocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Activation of T cells by the ragged tail of MHC class II-presented peptides of the measles virus fusion protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Processing of DR1-restricted determinants from the fusion protein of measles virus following two distinct pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Identification of an association between HLA class II alleles and low antibody levels after measles immunization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Naturally processed measles virus peptide eluted from class II HLA-DRB1*03 recognized by T lymphocytes from human blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Influence of HLA-DRB1 alleles on lymphoproliferative responses to a naturally processed and presented measles virus phosphoprotein in measles immunized individuals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Peptide vaccines against cancer, infectious diseases, and conception

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100389

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100389

1 reference

17 August 2017

1 reference